Spot, which publishes this research, gets quotes from 50+ providers, picks the options that fit your coverage and budget, and manages renewals after you buy. The first consultation is free. Book a free consultation
A diagnostics business may run a testing service, sell a test or instrument, or do both. Before a customer launch or lab expansion, describe which entity handles specimens, reports results, interprets findings, and manufactures products; those roles give a broker a clearer basis for comparing proposed terms.
Consider professional errors and omissions (E&O), product liability, cyber liability, commercial property, and equipment breakdown. Start with the coverages tied to your day-to-day operations, then use the situations and buying questions below to compare your options.
You analyze specimens, interpret results, or provide testing services to providers, employers, or consumers.
NAIC’s overview explains medical professional liability for licensed health professionals; it does not establish whether your laboratory entity qualifies. Ask the broker to map laboratory testing, result reporting, and interpretation to the proposed terms.[3][1][2]
Which services, result types, entities, and professionals are insured, and what exclusions apply to testing errors or interpretation?
You sell or distribute an assay, instrument, test kit, or other diagnostic product in addition to laboratory services.
FDA defines IVDs as reagents, instruments, and systems intended to diagnose disease or other conditions, including determine health status, using human specimens. Classification affects the product’s regulatory pathway. List each product’s intended use and ask how the proposed terms treat device-related allegations.[2]
Are each product, intended use, sales territory, and product stage described, and what exclusions or limits apply to a claim involving the product?
Your lab receives patient results or maintains health information for a provider or another covered organization.
HHS ties business-associate status to the service and data relationship, and NAIC says cyber terms are customized. Compare the exact terms for your data, vendors, response costs, and customer claims.[4][5][6]
Which patient data, lab systems, vendors, incident costs, and third-party claims are within the proposed cyber wording?
You lease a lab, install analyzers or freezers, or keep samples, inventory, or customer property at a site.
California’s commercial guide distinguishes property at a location from movable property and asks buyers to compare values and covered causes. List the actual sites and property rather than relying on a general lab description.[7]
Which equipment, samples, inventory, and customer-owned property are scheduled at each site, and what values, causes of loss, and deductibles apply?
A failed analyzer, freezer, or other machine could disrupt testing or damage work in progress.
Ask whether the proposed equipment-breakdown terms address the named machine and failure you are concerned about, and compare covered causes and any business-income terms.[7]
Which machines and breakdown causes are listed, and do the terms address resulting property damage, temporary equipment, or interruption costs?
Before you add a provider customer or sell a test, tell the broker whether you perform testing, report patient-specific results, interpret findings, manufacture an assay, or combine these activities. CMS says some testing of human specimens needs a CLIA certificate and lists exceptions; the specific facility activity matters.[1]
Use each product’s actual intended use and role in care to frame the insurance application, rather than relying on a broad label such as diagnostics.[2]
When you add a site or testing instrument, update the property schedule with its location, value, and use. If the equipment is essential, ask separately about breakdown terms and the specific machine and losses they address.[7]
If results move through a provider’s system, map which entity receives, maintains, and transmits the information. HHS says business-associate status depends on the service and protected-health-information relationship; do not assume every lab or vendor has the same status.[4]
Yes. A lab may perform testing and report results while another part of the business develops or sells an assay or instrument. FDA treats an IVD as a product with a specific intended use, so list the service and each product separately for the quote.[2]
Read the Full AnswerNo. CMS’s CLIA guidance concerns laboratory testing and certificates; it does not determine policy coverage. Use the facility’s testing role to describe operations, then ask the broker to identify the terms that apply to your services and products.[1]
Read the Full AnswerCheck whether the lab’s actual human-specimen testing activity is described in CMS’s CLIA guidance.
Describe an assay or instrument by intended use and product role when preparing the application.
Review the guide’s general property and machinery topics, then confirm terms in your proposed forms.
Spot, a product of Tools for Enlightenment, publishes this guide and works in the commercial insurance market. This is general buyer education; policy terms and state-specific obligations determine coverage and requirements.
Updated 2026-09-28. Editorial Policy
Spot, which publishes this research, gets quotes from 50+ providers, picks the options that fit your coverage and budget, and manages renewals after you buy. The first consultation is free. Book a free consultation
